Literature DB >> 9750444

[The effect of intraoperative high-dose tranexamic acid on blood loss after operation for acute aortic dissection].

Y Shimamura1, M Nakajima, T Hirayama, H Misumi, T Shimokawa, H Uesugi, K Uemura.   

Abstract

The effect of high dose tranexamic acid on blood loss after operations for acute aortic dissection was evaluated. Twenty-eight patients undergoing emergent operations for acute aortic dissection were studied. There were two groups, group T with 13 patients (group T) who were given 7 g of tranexamic acid after induction of anesthesia and 3 g of it after CPB and group C with 15 patients who did not receive tranexamic acid. There was a tendency that group T had less bleeding during operation and after operation (559.6 +/- 865.8 ml in group T and 805.8 +/- 442.9 ml in group C, 1719.2 +/- 1008.7 ml in group T and 3547.7 +/- 4580.1 ml in group C, respectively), but there was no significant difference between two groups. The removal of drainage tubes after operation was significantly earlier in group T (5.0 +/- 2.3 post operative day in group T and 8.1 +/- 5.2 post operative day in group C; p < 0.05). FDP and D-dimer level as measures of fibrinolytic activity were elevated at pre- and postoperative period in both groups, but they tended to be lower in group T at postoperative period. One patient required reexploration because of excessive bleeding and no mediastinal infection was reported in group T, whereas 4 patients underwent reexploration and 2 patients developed mediastinitis in group C. There were 5 hospital death (33.3%) in group C and 2 (15.4%) in group T. High dose of tranexamic acid seems to control fibrinolytic activity, thereby reducing blood loss and requirements, which may contribute to lower morbidity and mortality in operations for acute aortic dissection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9750444     DOI: 10.1007/bf03217790

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  18 in total

1.  Additional postbypass administration of tranexamic acid reduces blood loss after cardiac operations.

Authors:  J Katoh; K Tsuchiya; W Sato; M Nakajima; Y Iida
Journal:  J Thorac Cardiovasc Surg       Date:  1997-04       Impact factor: 5.209

2.  Retinal artery occlusion associated with tranexamic acid therapy.

Authors:  M R Parsons; D R Merritt; R C Ramsay
Journal:  Am J Ophthalmol       Date:  1988-06-15       Impact factor: 5.258

3.  Increased fibrinolytic activity in patients undergoing cardiopulmonary bypass operation.

Authors:  O Kucuk; H C Kwaan; J Frederickson; L Wade; D Green
Journal:  Am J Hematol       Date:  1986-11       Impact factor: 10.047

4.  Pharmacokinetics of tranexamic acid after intravenous administration to normal volunteers.

Authors:  O Eriksson; H Kjellman; A Pilbrant; M Schannong
Journal:  Eur J Clin Pharmacol       Date:  1974-08-23       Impact factor: 2.953

5.  Prophylactic tranexamic acid decreases bleeding after cardiac operations.

Authors:  J C Horrow; J Hlavacek; M D Strong; W Collier; I Brodsky; S M Goldman; I P Goel
Journal:  J Thorac Cardiovasc Surg       Date:  1990-01       Impact factor: 5.209

6.  Letter: Tranexamic acid and intracranial thrombosis.

Authors:  E Rydin; P O Lundberg
Journal:  Lancet       Date:  1976-07-03       Impact factor: 79.321

Review 7.  Hemostasis defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits.

Authors:  R L Bick
Journal:  Semin Thromb Hemost       Date:  1985-07       Impact factor: 4.180

8.  Plasma fibrinolytic activity in patients undergoing major abdominal surgery.

Authors:  G Mellbring; S Dahlgren; B Wiman
Journal:  Acta Chir Scand       Date:  1985

9.  Pharmacokinetics and bioavailability of tranexamic acid.

Authors:  A Pilbrant; M Schannong; J Vessman
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

10.  Prevention of bleeding after cardiopulmonary bypass with high-dose tranexamic acid. Double-blind, randomized clinical trial.

Authors:  J M Karski; S J Teasdale; P Norman; J Carroll; K VanKessel; P Wong; M F Glynn
Journal:  J Thorac Cardiovasc Surg       Date:  1995-09       Impact factor: 5.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.